4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-006044
SVP & Chief Operating Officer sold 63,000 shares at $42.82 ($2,697,660)
- SVP & Chief Operating Officer acquired 63,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nicholson John SVP & Chief Operating Officer | 2019-01-28 | Option exercise | +63,000 | $10.69 | $673,470 | 237,477 | D |
| Nicholson John SVP & Chief Operating Officer | 2019-01-28 | Sale | −63,000 | $42.82 | $2,697,660 | 174,477 | D |
| Derivatives | |||||||
| Nicholson John SVP & Chief Operating Officer | 2019-01-28 | Option exercise · Stock Option | −63,000 | $10.69 | $673,470 | 0 | D |
| Open-market sales · 63,000 sh · avg $42.82 · $2,697,660 | |||||||
Loading xslF345X03/doc4.xml…